As part of the 23rd International Congress of the European Association for cranio-maxillo-facial surgery team of Russian scientists presented the report «The use of the drug Refnot® (α-tumor necrosis factor-thymosin-α1) in patients with disseminated skin melanoma».
Reshetov I.V., Reshetnikov A.V., Abramov A.A., Kirpa-Ivanova E.A., Pimanchev P.V.
(I.M. Sechenov First Moscow State Medical University)
Download the presentation